Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

NCT00370721 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: bevacizumab

Sponsor

Shahid Beheshti University of Medical Sciences